Table 1.
Investigators | Number of patients | Clopidogrel loading dose | Resistance |
---|---|---|---|
Jaremo et al (J Invest Med.2002;252:233) | 18 | 300 | 28% |
Gurbel et al (Circulation 2003;107:2908) | 92 | 300 | 31–35% |
Muller et al (Thromb Haemost 2003;89:783) | 105 | 600 | 5–11% |
Mobley et al (Am J Cardiol 2004;93:456) | 50 | 300 | 30% |
Lepantalo et al (Eur Heart J 2004;25–476) | 50 | 300 | 40% |
Angiolillo et al (Thromb Res 2005;115:101) | 48 | 300 | 44% |
Matetzky et al (Circulation 2004;109:3171) | 60 | 300 | 25% |
Dzieweierz (Kardiol Pol 2005;62:108) | 31 | 300 | 23% |
Gurbel et al (J Am Coll Cardiol 2005;45:1392) | 192 | 300/600 | 8–32% |
Lev et al (J Am Coll Cardiol 2006;47:27) | 150 | 300 | 24% |
5–44% |
Data adapted from: Gurbel PA, Tantry US. Clopidogrel Resistance? Thromb Res. 2007; 120(3):311–21. Epub 2006 Nov 14.